Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice
2021 · Acta Pharmaceutica Sinica B · 100 citations
https://doi.org/10.1016/j.apsb.2021.03.038
E
Eryun Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
1.6K
Citations
20
h-index
21
i10-index
Eryun Zhang is an academic researcher from Jiangnan University. The author has contributed to research in topics: Fullerene Chemistry and Applications & Graphene research and applications & Diet and metabolism studies. The author has an h-index of 20, co-authored 35 publications.
ORCID: 0000-0003-3862-3839Papers by this author
works20(S)-Protopanaxadiol enhances angiogenesis via HIF-1α-mediated VEGF secretion by activating p70S6 kinase and benefits wound healing in genetically diabetic mice
2017 · Experimental & Molecular Medicine · 62 citations
https://doi.org/10.1038/emm.2017.151
A gut feeling for drugs that have metabolic benefits
2023 · Nature Communications · 6 citations
https://doi.org/10.1038/s41467-023-40167-3
Plant-based bioactives and oxidative stress in reproduction: anti-inflammatory and metabolic protection mechanisms
2025 · Frontiers in Nutrition · 4 citations
https://doi.org/10.3389/fnut.2025.1650347
Inherent immunity and adaptive immunity: Mechanism and role in AECOPD
2025 · Innate Immunity · 1 citations
https://doi.org/10.1177/17534259251322612
Mitochondrial homeostasis: A key regulator in endometrial physiology and pathology
2025 · Drug Discovery Today · 1 citations
https://doi.org/10.1016/j.drudis.2025.104519
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat